Patient P-01670

Synthetic patientNBL-101 · Day 91 · 35–44 · M · baseline S11Steering view · 3D Open companion preview

Therapy response

Stable

Tolerance

Favorable

GI state

Favorable

Inflammatory state

Favorable

Nutritional resilience

Favorable

Discontinuation risk

16%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events

solid = observed · dashed = predicted

Day 0 NBL-101 started — Baseline state S11

What changed?

Trajectory is tracking the baseline prediction.

Primary contributors, last 14 days

GI instability-3
Nutritional resilience+3
Inflammatory activity+2
Toxicity-2

What helped?

No interventions yet.

LIFE OS recommendation

No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.

Daily trackers

Molecule settings

The trackers this program marks as important, last 14 days vs the 14 before.

GI burden

Companion

27.4/100

worsening · +2.2 vs previous 14 d

Toxicity

Blood

16.8/100

improving · -4.1 vs previous 14 d

Sleep quality

Wearable

30.5/100

worsening · -2.7 vs previous 14 d

Energy level

Daily log

5.5/10

stable · -0.2 vs previous 14 d

Stress level

Daily log

4.3/10

stable · +0.1 vs previous 14 d

Steps

Wearable

6,184

improving · +728 vs previous 14 d

Adherence

Companion

96.6 %

stable · +1.2 vs previous 14 d

This trajectory is doing well — what to keep, what to watch

Steering view →

Heading towards restoration · 65 from the failing basin, 23 from restoration.

Good elements to keep

Butyrate producers intact
hidden · steering +7.5
Daily walks resumed
perturbation · steering +3.3

Main detractors to watch

Histamine load
perturbation · steering -12.5
FUT2 non-secretor
hidden · steering -10.6
Alcohol
perturbation · steering -7.7
IL6 high-expression variant
hidden · steering -7.3
Histamine load
detractor · GI +6.3 next day
Alcohol
detractor · GI +4.5 next day

State influencers · digestive

Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.

Histamine load
+6.3detractor · 95%
Alcohol
+4.5detractor · 95%
Spicy / capsaicin
+3.9detractor · 91%
Dietary fat load
+1.9no signal · 36%
Simple carbohydrates
-0.5no signal · 15%
Insoluble fibre
+0.5no signal · 15%

Biological layers

Which pathways look influenced, and by which layer of this person's biology.

Pathways under pressure

Mucosal barrier integrity ↓70
- DNAFUT2 non-secretor lowers mucosal fucosylation
- MicrobiomeAkkermansia low → thinner mucus layer
- WearableSleep 5.9 h, below personal baseline
Inflammatory signalling ↑25
- DNAIL6 -174 variant raises baseline inflammatory tone
Autonomic recovery ↓20
- WearableShort sleep window

DNA

Fictional pharmacogenomic panel

FUT2 rs601338 AA (non-secretor)
Reduced mucosal fucosylation
IL6 -174 G/C
Higher inflammatory tone
CYP2D6 Normal metabolizer
Expected exposure

Microbiome

Shannon diversity 3.1 · butyrate capacity 68/100

Akkermansia muciniphilaLow
Faecalibacterium prausnitziiNormal
Bacteroides fragilisNormal
Bifidobacterium longumLow
EnterobacteriaceaeNormal

Wearable, last 14 days

daily evolution fed into the runtime

HRV: 47 ms
Sleep: 5.6 h
Steps: 4,917
Resting HR: 58 bpm

Daily log: GI score 27, nutritional resilience 62, adherence 97.

What this patient sees in NostraAI

The content that steers the trajectory: what to eat, what to do, what to take.

Open companion preview

What to eat

Keep meals regular; three to four moderate portions spaced through the day
Include a cooked vegetable portion with each main meal
Keep fibre steady; no new sources this week
Avoid known triggers for now: fried or oily food, dairy, alcohol

What to do

Log the daily check-in; one line is enough
Keep the current walking rhythm
Protect a 7.5-hour sleep window; screens off 30 minutes before
Keep hydration steady: small amounts through the day rather than large volumes at once

What to take

Take the scheduled dose as agreed with your care team
No additional supplements this week
Fictional demo item: continue vitamin D as before

284 biologically similar trajectories

Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

Patient	Similarity	Baseline	Intervention	Outcome	Response today
P-01430	53%	S05	CR-01	improved	54
P-01571	44%	S13	SC-12	improved	57
P-01804	41%	S19	AD-05	improved	61
P-01342	38%	S11	DT-01	improved	48
P-01724	38%	S10	DT-01	improved	63
P-01752	38%	S20	DT-01	improved	50
P-01593	37%	S10	HY-01	improved	56
P-01346	36%	S12	DT-01	improved	52
P-01555	36%	S06	GI-04	improved	56
P-01861	36%	S12	HY-01	improved	47
P-01374	35%	S08	HY-01	improved	49
P-01455	35%	S01	GI-04	improved	61